New developments in the burgeoning field of cannabinoid research
By Nate Seltenrich on July 07, 2021
A new paper out of Canada caught our eye because it evaluated a range of outcomes among a large number of patients at a medical cannabis clinic in Quebec (279, to be exact) who had used both CBDand THC in the course of their daily lives over a period of up to six months.
Published in the Journal of Cannabis Research, the paper includes some intriguing results – with the important caveat (common to all real-world or “naturalistic” observational studies due to the lack of a control group) that a cause-effect relationship cannot be inferred. Compared to their scores at baseline, participants with moderate or severe symptoms reported experiencing considerably less pain, anxiety, and depression, and greater wellbeing, after three months of formal treatment. After six months, the improvements held relatively steady. However, these improvements were not seen in participants categorized as having only mild symptoms.